All Comments by Paul Coleman

  1. Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls.
  2. The Alzheimerization of aging: a brief update.
  3. Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease.
  4. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
  5. Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent.
  6. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease.
  7. Reduction of O-linked N-acetylglucosamine-modified assembly protein-3 in Alzheimer's disease.
  8. Accumulation of SNAP-25 immunoreactive material in axons of Alzheimer's disease.
  9. A beta peptide deposition in the brains of transgenic mice: evidence for a key event in Alzheimer's disease pathogenesis.
  10. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.
  11. Role of sphingolipid-mediated cell death in neurodegenerative diseases.
  12. The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease.
  13. PEP-19 immunohistochemistry defines the basal ganglia and associated structures in the adult human brain, and is dramatically reduced in Huntington's disease.
  14. Link Between Education Level and AD Risk Strengthened